SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Marvel Biosciences awards 50,001 deferred share units to independent directors

Marvel Biosciences Corp. (and its wholly owned subsidiary) announced the award of 50,001 deferred share units (DSUs) to its three independent directors.

MRVL

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories